Leading longevity investors by deal count (Longevity Investors Conference) 2025
Leading longevity investors by deal count (Longevity Investors Conference) 2025 by Longevity Investors Conference: 10 investors ranked, led by GV. Full list with...
GV leads with 81 longevity deals, ahead of ARCH Venture Partners (52) and Casdin Capital (49). The NIH appears 9th with 25 deals.
The full list
| Rank | Name |
|---|---|
| 1 | GVDeals: 81 |
| 2 | ARCH Venture PartnersDeals: 52 |
| 3 | Casdin CapitalDeals: 49 |
| 4 | Polaris PartnersDeals: 39 |
| 5 | Alexandria Venture InvestmentsDeals: 38 |
| 6 | Khosla VenturesDeals: 38 |
| 7 | Perceptive AdvisorsDeals: 32 |
| 8 | Foresite CapitalDeals: 26 |
| 9 | National Institutes of Health (NIH)Deals: 25 |
| 10 | OrbiMedDeals: 25 |
Is this page right?How the research works